ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationPantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber et al.|European Heart Journal|2012Cited by 6.8k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgerySigrun Halvorsen, Volkmar Falk, Julinda Mehilli et al.|European Heart Journal|2022Cited by 1.1k
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Robert Scott-Millar, Jean‐Philippe Collet et al.|EP Europace|2017Cited by 137
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rosselló, John Munkhaugen, Eva Prescott et al.|The Lancet|2025Cited by 63
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Dan Atar, Vidar Ruddox et al.|American Heart Journal|2018Cited by 50